njruich 2012-11-20 17:22 IP:南京
需要意大利药典标准的匹多莫德口服溶液的标准,不是欧洲药典的,如果有请报价   [更多]
悬赏:
悬赏
¥0.00
载入中...
changxin 2012-11-02 11:57 IP:重庆
PXE国际关于弹性假黄瘤(PXE)的研究团队,对其的病因提出了现有的两种假设:积极的循环代谢产物或者组织特异性功能障碍。任务要求提供数据来求证这两种假设或其中之一。根据各地的发病机制进行实验,进一步了解PXE的病因。 这项任务保证至少会奖励一名挑战者,并且,除了任务奖金之外,PXE国际还将对中标者给予PXE的研究经费资助。 征稿件请直接上传网址:https://www.innocentive.com PXE – Evaluating Hypotheses and Suggesting Experiments for a Rare Disease TAGS: Computer Science/Information Technology, Chemistry, Global Health, Nature, Public Good, Life Sciences, Ideation AWARD: $7,000 USD | DEADLINE: 11/30/12 | ACTIVE SOLVERS: 38 | POSTED: 10/31/12 The Seeker, PXE International, the primary group responsible for funding PXE research, presents two existing hypotheses (an active circulating metabolite(s) or a tissue-specific dysfunction) for the rare disease Pseudoxanthoma Elasticum (PXE). The Seeker requests that Solvers present evidence favoring one of the two hypotheses, then provide additional experiments to conduct to further knowledge around the disease mechanism. This is an Ideation Challenge with a guaranteed award for at least one submitted solution. In addition to the Challenge award, PXE International will also assist finalists in efforts to obtain funding for PXE-related research. Detailed Description & Requirements INTRODUCTION TO PXE Pseudoxanthoma Elasticum (PXE) is a recessive genetic disorder with signs and symptoms that mimic many aspects of the normal aging process, but at a much younger age (when people are roughly between 10 and 20 years old). Specifically, the disease is characterized by fragmentation and mineralization of elastic fibers in certain tissues. Some of the more common symptoms, in general order that they occur, are: Wet-type macular degeneration Skin wrinkling Calcification of blood vessels Cardiovascular disease PXE is a rare disease with an estimated patient population of 12,000 people. Given the small number of people with the disease, it has not been the subject of research by for-profit pharmaceutical and biotech companies.   [更多]
悬赏:
悬赏
¥0.00
载入中...
changxin 2012-09-26 21:59 IP:重庆
任务材料需要提供与化合物相匹配的核心结构和每种化合物合成的详细的参考依据。合格者会得到一定的奖励。将给予每种化合物知识产权转让费9000元,非独家许可使用化合物,以达到研究目的,比如:研究化合物分子的性质和分子衍生物。 Seeking Bicyclic Aminoketones AWARD: varies | DEADLINE: 10/22/12 | ACTIVE SOLVERS: 24 | POSTED: 9/21/12 Source: InnoCentive Challenge ID: 9932910 Type: RTP Detailed Description & Requirements Intellectual Property: In return for the Initial Transfer Fee of $1,500 per compound, you are expected to grant the Seeker only a non-exclusive license to use your compound for internal, research purposes (for example, researching the molecule’s properties or preparing derivatives of the molecule). Material supply of non-commercial compounds matching the shown core structures is desired. For Solvers’ information, procedures for preparing compounds of this type may be found in the following references: Synthesis, 1, 1979, 50. Synthesis, 3, 2010, 493. Tetrahedron, 68 (4), 2012, 1286. J. Organic Chem, 73 (6), 2008, 2114. J. Med. Chem, 37 (18), 1994, 2831. More specifically, the Seeker is looking for compounds that meet the following Requirements: Structure: FeatureRange StructureA bicyclic aminoketone as shown in the structures above. Elements in R and A groupsR = H, Me, or protecting group (preferably Boc) A = A 1-3 membered linker where one atom may be N, O, or S Substituents– In addition to H, the core rings and/or the A linker may be substituted with Me or F. Unsaturation– The core rings and/or the A linker may include an olefin, including an exo olefin, but may not contain any additional carbonyl groups. Additional Rings– The Seeker would prefer compounds that have only the bicyclic structure shown above, however, they may consider compounds with an additional ring fused to the core bicycle. Stereochemistry– The Seeker will only consider compounds which are single diastereomers. In cases where the compound may exist as two enantiomers, the Seeker will consider   [更多]
悬赏:
悬赏
¥0.00
载入中...
changxin 2012-09-27 11:01 IP:重庆
这项任务要要求设计一个自动化的,高通量的仪器 , 可以定量地和可重复地测定的油水乳化液的分离。 这个任务需要提交一份书面建议书。 An Instrument for Quantitative, Reproducible Characterization of Water/Oil Emulsions AWARD: $30,000 USD | DEADLINE: 10/15/12 | ACTIVE SOLVERS: 508 | POSTED: 8/15/12 Source: InnoCentive Challenge ID: 9933086 Type: Theoretical-IP Transfer Detailed Description & Requirements The presence of emulsions in oil operations is common and generally undesirable. Crude oil emulsions typically form due to the presence of naturally occurring emulsifying agents (asphaltenes, resins, etc.) in crude oil. The high cost associated with transportation and corrosion of equipment is one of the problems caused by the presence of water in the crude oil. Therefore, oil dehydration is required, which is often achieved through chemical treatment using demulsifiers. While the Seeker has identified ~200 liquid “demulsifier” agents, compounds that in amounts of ~100-500 ppm can aid in the resolution of the water and oil phases, they lack a quantitative and reproducible assay for determining demulsifier effectiveness at resolving the emulsion. Currently, the Seeker performs a “bottle test” in which they add ~15-100 mL of the emulsion into a bottle, add the different demulsifiers, shake, and then visually observe which bottles show the best phase separation. This assay clearly relies on visual detection by a trained observer and is not nearly as quantitative or reproducible as the Seeker desires. Results from a bottle test with the same emulsion and three different demulsifiers are shown below. The bottle on the left has clearly not been resolved into two distinct phases. While the middle bottle shows significant improvement, careful inspection of the phase boundary shows a slight amount of oil contaminating the water layer and a slightly undefined interface. Finally, the bottle on the right shows an optimally resolved two-phase system with a very clear oil/water phase boundary. Important Note:   [更多]
悬赏:
悬赏
¥0.00
载入中...
永达化工 2012-09-24 14:31 IP:济南
Disulfiram 我想要一份USP版本的分析单   [更多]
悬赏:
悬赏
¥0.00
载入中...
csc 2012-05-10 10:51 IP:重庆
目前公司金银花绿原酸粗提产品总灰分超标,高达15%---20%。原材料灰分符合国家药典标准,在10%以内,但提取,过滤,纳滤浓缩,复浓缩之后,滤袋过滤,喷雾干燥,得到的产品总灰分高达18%,有的高过20%,我们生产过程中用的水都是RO反渗透纯化水。 希望有关专家现场指导或合作开发处理   [更多]
悬赏:
悬赏
¥0.00
载入中...
taideng 2012-03-07 23:02 IP:重庆
1.要求是中国药典2010年版一部word版,不是二部、三部,也不是pdf版 2.要求word版是正式的标准,而不是标准修改稿 3.不需要中药材部份(我已有),只需要中成药部分 4.要求基本没有错误,不有用PDF的复制或转化,这样错误太多。 5.网上随便搜索来的东西我已有,都不符合上面的要求,请不要投稿   [更多]
悬赏:
悬赏
¥0.00
载入中...
12580 2012-03-01 16:46 IP:合肥
X20010169   30mg的   [更多]
悬赏:
悬赏
¥0.00
载入中...
凯莎 2012-02-09 09:55 IP:北京
求购欧洲药典EP7.1、EP7.2以及EP7.3,只有其中一个也可以,最好是三个都有。   [更多]
悬赏:
悬赏
¥0.00
载入中...
tyl791128 2012-02-15 14:24 IP:遂宁
需求阿莫西林胶囊微生物限度验证方案,准确的回收率。因本人用薄膜过滤法操作,枯草芽孢杆菌无法回收回来,请各位高手支招。冲洗量是多大?青霉素酶用多大单位,多少量?   [更多]
悬赏:
悬赏
¥0.00
载入中...
发布需求,坐等药智客上门
  • 安全可靠,先验收再正式付款
  • 性价比超高,节省一半费用
  • 80%的需求得到了圆满解决
立即发布需求

推荐任务